Literature DB >> 16678027

Improved survival after acute myocardial infarction complicated by cardiogenic shock with circulatory support and transplantation: comparing aggressive intervention with conservative treatment.

Wakkas Tayara1, Randall C Starling, Mohamad H Yamani, Oussama Wazni, Fuad Jubran, Nicholas Smedira.   

Abstract

BACKGROUND: The prognosis for patients with myocardial infarction has steadily improved, but remains poor for those developing cardiogenic shock. Utilization of re-vascularization, mechanical circulatory support and transplantation in these patients may improve survival.
METHODS: We retrospectively analyzed the clinical outcome of 138 consecutive patients at the Cleveland Clinic from 1992 to 1998 who met the criteria for cardiogenic shock after acute myocardial infarction. All patients received intensive medical therapy and intra-aortic balloon pump support. Forty-three patients received intensive medical therapy (conservative group) and 95 patients were treated aggressively (aggressive group). The aggressive group comprised patients who were treated with percutaneous intervention/coronary artery bypass grafting (n = 77, re-vascularization group), and patients who received circulatory support/cardiac transplantation (n = 18).
RESULTS: The baseline demographics and angiographic and hemodynamic features were comparable for the two groups. The in-hospital mortality rate was significantly reduced in the aggressive group compared with the conservative group (54% vs 81%, p = 0.002). The in-hospital mortality rate of the circulatory support/transplant group was markedly reduced compared with the conservative group (33% vs 81%, p < 0.001), and was also significantly lower than that of the re-vascularization group (33% vs 63%, p= 0.03). The aggressive group had a markedly improved 5-year survival compared with the conservative group (30% vs 6.2%, p = 0.003).
CONCLUSIONS: These data suggest that an aggressive strategy, particularly left ventricular assist device support as a bridge to heart transplantation, may improve survival in post-myocardial infarction patients with cardiogenic shock.

Entities:  

Mesh:

Year:  2006        PMID: 16678027     DOI: 10.1016/j.healun.2005.10.011

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  12 in total

Review 1.  Percutaneous left ventricular assist devices during cardiogenic shock and high-risk percutaneous coronary interventions.

Authors:  Stéphane Cook; Stephan Windecker
Journal:  Curr Cardiol Rep       Date:  2009-09       Impact factor: 2.931

Review 2.  Emergency cardiac surgery in patients with acute coronary syndromes: a review of the evidence and perioperative implications of medical and mechanical therapeutics.

Authors:  Charles Brown; Brijen Joshi; Nauder Faraday; Ashish Shah; David Yuh; Jeffrey J Rade; Charles W Hogue
Journal:  Anesth Analg       Date:  2011-03-08       Impact factor: 5.108

3.  Use of adenosine diphosphate receptor inhibitor prior to left ventricular assist device implantation is not associated with increased bleeding.

Authors:  Anjan Tibrewala; Michael E Nassif; Adam Andruska; Jerrica E Shuster; Eric Novak; Justin M Vader; Gregory A Ewald; Shane J LaRue; Scott Silvestry; Akinobu Itoh
Journal:  J Artif Organs       Date:  2016-11-09       Impact factor: 1.731

4.  Mechanical circulatory support device-heart hysteretic interaction can predict left ventricular end diastolic pressure.

Authors:  Brian Y Chang; Steven P Keller; Sonya S Bhavsar; Noam Josephy; Elazer R Edelman
Journal:  Sci Transl Med       Date:  2018-02-28       Impact factor: 17.956

Review 5.  Cardiogenic shock in ACS. Part 2: Role of mechanical circulatory support.

Authors:  Stephen Westaby; Kyriakos Anastasiadis; George M Wieselthaler
Journal:  Nat Rev Cardiol       Date:  2012-01-10       Impact factor: 32.419

6.  Stem cell therapy of myocardial infarction: a promising opportunity in bioengineering.

Authors:  Bin Jiang; Li Yan; James G Shamul; Maxwell Hakun; Xiaoming He
Journal:  Adv Ther (Weinh)       Date:  2020-02-03

7.  Dynamic Modulation of Device-Arterial Coupling to Determine Cardiac Output and Vascular Resistance.

Authors:  Steven P Keller; Brian Y Chang; Qing Tan; Zhengyang Zhang; Ahmad El Katerji; Elazer R Edelman
Journal:  Ann Biomed Eng       Date:  2020-04-13       Impact factor: 3.934

Review 8.  Cardiogenic Shock: Failure of Oxygen Delivery and Oxygen Utilization.

Authors:  Hoong Sern Lim
Journal:  Clin Cardiol       Date:  2016-08-10       Impact factor: 2.882

Review 9.  Percutaneous ventricular assist devices for cardiogenic shock.

Authors:  Stéphane Cook; Stephan Windecker
Journal:  Curr Heart Fail Rep       Date:  2008-09

10.  Percutaneous ventricular assist devices: new deus ex machina?

Authors:  Diego Arroyo; Stéphane Cook
Journal:  Minim Invasive Surg       Date:  2011-07-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.